ANGIOGENESIS INHIBITORS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA

• Asıl Yazarlar: Massimiliano Berretta (Yazar), Luca Rinaldi (Yazar), Fabrizio Di Benedetto (Yazar), Arben Lleshi (Yazar), Valli De Re (Yazar), Gaetano Facchini (Yazar), Paolo De Paoli (Yazar), Raffaele Di Francia (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2016-11-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: Angiogenesis inhibitors have become an important therapeutic approach in the treatment of hepatocellular carcinoma (HCC) patients. The achievement of Sorafenib in prolonging overall survival of patients with HCC makes therapeutic inhibition of angiogenesis a fundamental element of the tr...